# Virtual Reality for the Mitigation of Anxiety During Intrathecal Administration in Participants With Spinal Muscular Atrophy

> **NCT05354414** · NA · COMPLETED · sponsor: **Biogen** · enrollment: 63 (actual)

## Conditions studied

- Spinal Muscular Atrophy (SMA)

## Interventions

- **DEVICE:** Virtual reality
- **PROCEDURE:** Standard of Care

## Key facts

- **NCT ID:** NCT05354414
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-11
- **Primary completion:** 2024-07-12
- **Final completion:** 2024-07-12
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354414, "Virtual Reality for the Mitigation of Anxiety During Intrathecal Administration in Participants With Spinal Muscular Atrophy". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05354414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*